Ministries join hands for combating drug resistance

Several ministries and Vietnam-based development partners have signed an aide-mémoire in Hanoi on June 24 on cooperation on fighting drug resistance.
Signatories included the Ministries of Health, Agriculture-Rural Development, Industry-Trade, and Natural Resources-Environment. Among the development partners are WHO, FAO, UNICEF, USAID and the CDC.
Delegates at the signing ceremony.
The deal forms part of the country's efforts to combat drug resistance in the fields of health care, agriculture and environment protection.
"Drug resistance has become a greater risk that is now threatening people's health and the economy of Viet Nam due to the increasing and uncontrolled use of antibiotics," said health minister Nguyen Thi Kim Tien at the signing ceremony.
Tien stressed that an alarming number of antibiotics can be found in food supply and ecological environment, while the legal framework and regulation system are currently inadequate for supervision, prevention and coping with the multilateral risks of drug resistance.
Tien said an overall collaboration on policy and action between ministries and sectors with support from the community and development partners would be an important foundation for combating drug resistance in Vietnam.
Under the framework of the aide-mémoire, the sides will take action together, following the 2013-2020 national action plan on combating drug resistance.
They will also work together to develop communication and education plans to strengthen the community's awareness on the reasonable use of antibiotics.
According to a 2009 survey on drug resistance, reported by 15 hospitals in Hanoi, HCM City, Hai Phong, Hue and Da Nang, 30-70 percent of gram-negative bacteria were resistant to cephalosporins of the third and fourth generations and nearly 40-60 percent were resistant to aminoglycosides and flouroquinolones.
On average, 274.7 defined daily doses (DDD) of antibiotics are consumed per 100 occupied bed days (100 day-bed) in Viet Nam. The rate was significantly higher compared to that of the Netherlands with 58.1 DDD/100 day-bed or that of hospitals in 30 European countries at 49.6 DDD/100 day-bed.
Chia sẻ bài viết ^^
Other post

All comments [ 10 ]

Gentle Moon 25/6/15 22:38

Until the research and development pipeline is consistently producing new antibiotics, there are other ways to combat resistance

Jane smartnic 25/6/15 22:38

Researchers are finding ways to extend the clinical utility of existing agents or those that have fallen out of favor. Many groups are working on optimizing the pharmacodynamics of older anti-infectives.

Love Peace 25/6/15 22:39

Using combination therapy to prevent resistance is a well-established approach in certain infections like tuberculosis

Pack Cassiopian 25/6/15 22:40

Now, “we might be able to have novel dosing strategies that allow us to get more squeeze out of these antibiotics.”

Deck Hero14 25/6/15 22:41

We’re trying to figure out how we can best use some of our remaining active drugs to optimize clinical outcomes and also to prevent the emergence of resistance

Only Solidar 25/6/15 22:42

Drug development, although critical, is just one piece of the puzzle. Reducing the spread of infection is just as important.

MaskOf Zero 25/6/15 22:42

Antibiotic stewardship — using the right antibiotic in the right patient at the right dose — is key.

yobro yobro 25/6/15 22:43

The challenge will be [developing] antibiotics directed at the most important unmet medical needs, which are these resistant gram-negatives, including Acinetobacter,

LawrenceSamuels 25/6/15 22:44

t is essential that antibiotic development continues beyond the 2020 goal set by the IDSA initiative.

John Smith 25/6/15 22:45

I hope [by 2020 that] the doomsday scenario of telling people they can’t get their heart transplant is further off in the future.”

Your comments